MARKET

MOLN

MOLN

MOLECULAR PARTNERS AG
NASDAQ
3.860
+0.050
+1.31%
Opening 12:11 06/24 EDT
OPEN
3.895
PREV CLOSE
3.810
HIGH
3.895
LOW
3.730
VOLUME
13.29K
TURNOVER
--
52 WEEK HIGH
5.36
52 WEEK LOW
3.410
MARKET CAP
144.79M
P/E (TTM)
-3.0446
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MOLN last week (0615-0619)?
Weekly Report · 2d ago
Weekly Report: what happened at MOLN last week (0608-0612)?
Weekly Report · 06/15 09:59
Weekly Report: what happened at MOLN last week (0601-0605)?
Weekly Report · 06/08 09:56
Analysts Offer Insights on Healthcare Companies: Disc Medicine (IRON), Molecular Partners (MOLN) and Park Dental Partners, Inc. (PARK)
TipRanks · 06/05 03:40
Molecular Partners Starts Dosing DLL3 Radio-DARPin MP0712, Highlights Program at ASCO and SNMMI 2026
TipRanks · 06/01 11:59
Molecular Partners starts Phase 1/2a study of DLL3-targeting Radio-DARPin MP0712 in SCLC and neuroendocrine cancers
PUBT · 06/01 11:19
Weekly Report: what happened at MOLN last week (0525-0529)?
Weekly Report · 06/01 09:59
Molecular Partners to hold trial-in-progress presentations on Phase 1/2a study
TipRanks · 05/31 20:30
More
About MOLN
Molecular Partners AG is a Switzerland-based company engaged in the pharmaceuticals industry. As a biopharmaceutical company, it is active in the research and development of proteins like DARPins (Designed Ankyrin Repeat Proteins), a new class of small proteins used for the development of medicine against diseases like cancer and sight-threating diseases, among others. The Company’s pipeline is structured mainly through three areas: Ophthalmology, including the creation of therapies for renital diseases like wet age-related macular degeration (wet AMD) and diabetic macular edema (DME); Oncology, containing the development of DARPins against cancer, among others; and Immunology and other Indications, entailing DARPins against several targets important for the treatment of inflammatory and auto-immune diseases.

Webull offers Molecular Partners AG (ADR) stock information, including NASDAQ: MOLN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MOLN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MOLN stock methods without spending real money on the virtual paper trading platform.